Tech Sell-Off Continues
Hey Scoopers,
After the better-than-expected job report, investors seemed confident but turned back to the bearish mood after Powellâs statements. â More on that in the “Overall Market” section.
Beyond the overall stock market, a biotechnology company closed a deal that skyrocketed its stock’s price. In contrast, a recent IPO has not met analystsâ expectations. â More on that in the “What’s Up?” and “What’s Down?” sections.
By the way, the line between payment companies and technology companies is getting quite blurry? â More on that in the “Water Cooler” section.
But, first, here is a recap of what happened in the market yesterday:
Market Recap
- U.S. markets: All the indices ended Thursday in the red. Scroll down to the “Overall Market” section to read more.
- Cryptocurrency: Bitcoin price pushed back to under $50K per coin.
IBD shares tips on how to make more money trading
Get 12 free stock market lessons delivered to your email from Investor’s Business Daily, the leader in investing education for over 35 years. Weâll cover the basics of better investing and show you how to give yourself an edge in the market
Get Free Lesson
(By clicking you agree to receive email updates and special offers from Investors Business Daily)
Powell NOT To The Rescue
The stock market closed in the red zone on Thursday for the third day in a row. The indices started the day close to the flat line after the better-than-expected jobs’ report. However, the stocks dipped sharply with another surge in the 10-Year Treasury rate. It ended the trading day at 1.54%.
After the Fed Chair’s public appearance at the WSJ Jobs Summit, investorsâ were disappointed that Powell would not attempt to forestall the inflationary pressures anytime soon. Following the statement, indices fell into the red zone.
Another Acquisition
So, what happened?
Shares of Five Prime Therapeutics (Ticker: FPRX) were up by more than 78% on Thursday. Five is a biotechnology company developing protein therapeutics. Yesterday’s spike came after Amgen (Ticker: AMGN) announcing Five Prime’s acquisition at $1.9 billion with a $38 purchase price per share. Amgenâs CEO Robert Bradway stated that Five Primeâs innovative pipeline strengthens Amgenâs oncology leading portfolio.
3 Monster Stocks That Could Reach New Highs in 2021
Stock market investing isn’t nearly as difficult as many professionals would have you believe…The truth is that by applying a reliable and consistent strategy anyone can build a portfolio that’s tailored to their particular retirement goals. To make things easier we have assembled a brand new report on how to find the best stocks and industries to invest in, along with our 3 top stocks for 2021.
Download the Stock Report Here (Free)
(By clicking you agree to receive email updates and special offers from FxTrade Group)
Not the Expected Results
So what happened?
Shares of Vroom (Ticker: VRM) were down by more than 27%. Vroom is a recent IPO that operates an e-commerce platform for used vehicles. After it announced a worse-than-expected fourth-quarterly loss, Wall Street turned its back to the company. Despite losing almost one-third of its market value, Vroomâs CEO stated that it is still confident about investing in the future.
Mastercard Going Tech
So what happened?
Mastercard (Ticker: MA) and Samsung (Ticker: SSNLF) have decided to change the way customers use payment cards. After the long-time partnership resulting in revenue growth for both sides, the duo announced a biometric card development partnership.
The idea is to develop a built-in fingerprint scanner on the payment cards, delivering a more secure transaction. The scanner would improve the payment method, turning it into a faster and more reliable payment source. CEOs from Mastercard and Samsung believe that the duo has enough safety and cybersecurity expertise to deliver the innovative endeavor.
These days the line between payment and technology is quite blurry.
If you have any questions, or suggestions let us know by emailing us at members@tradestocks.com. We look forward to hearing from you.